Connection

Richard Silver to Pulmonary Fibrosis

This is a "connection" page, showing publications Richard Silver has written about Pulmonary Fibrosis.
Connection Strength

3.235
  1. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis. Arthritis Rheumatol. 2023 03; 75(3):438-448.
    View in: PubMed
    Score: 0.745
  2. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 2014 Mar; 66(3):485-7.
    View in: PubMed
    Score: 0.402
  3. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum. 2011 May; 63(5):1416-25.
    View in: PubMed
    Score: 0.330
  4. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol Rep. 2005 Apr; 7(2):135-41.
    View in: PubMed
    Score: 0.217
  5. Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma). Clin Exp Rheumatol. 2004 Jan-Feb; 22(3 Suppl 33):S38-46.
    View in: PubMed
    Score: 0.199
  6. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997 Apr; 40(4):743-51.
    View in: PubMed
    Score: 0.124
  7. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
    View in: PubMed
    Score: 0.099
  8. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol. 1993 May; 20(5):838-44.
    View in: PubMed
    Score: 0.095
  9. Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin Arthritis Rheum. 2011 Oct; 41(2):212-22.
    View in: PubMed
    Score: 0.080
  10. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med. 1990 May; 88(5):470-6.
    View in: PubMed
    Score: 0.077
  11. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis. 2010 Jun; 69(6):1220-6.
    View in: PubMed
    Score: 0.077
  12. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Am Rev Respir Dis. 1990 Feb; 141(2):301-6.
    View in: PubMed
    Score: 0.076
  13. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med. 1989 Nov; 87(5):525-7.
    View in: PubMed
    Score: 0.074
  14. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum. 2009 Nov; 60(11):3455-64.
    View in: PubMed
    Score: 0.074
  15. Outcome measures in the lung. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v48-50.
    View in: PubMed
    Score: 0.069
  16. Histopathology and bronchoalveolar lavage. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v62-4.
    View in: PubMed
    Score: 0.069
  17. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34.
    View in: PubMed
    Score: 0.064
  18. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7.
    View in: PubMed
    Score: 0.063
  19. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. Arthritis Rheum. 1986 Apr; 29(4):525-31.
    View in: PubMed
    Score: 0.058
  20. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin Exp Rheumatol. 2004 Nov-Dec; 22(6):733-42.
    View in: PubMed
    Score: 0.053
  21. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):28-35.
    View in: PubMed
    Score: 0.050
  22. M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo. Transl Res. 2016 Apr; 170:99-111.
    View in: PubMed
    Score: 0.028
  23. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 2015 Jun; 44(6):680-6.
    View in: PubMed
    Score: 0.026
  24. Thrombin increases lung fibroblast survival while promoting alveolar epithelial cell apoptosis via the endoplasmic reticulum stress marker, CCAAT enhancer-binding homologous protein. Am J Respir Cell Mol Biol. 2014 May; 50(5):893-902.
    View in: PubMed
    Score: 0.025
  25. Lung disease in systemic sclerosis (scleroderma). Baillieres Clin Rheumatol. 1993 Feb; 7(1):79-97.
    View in: PubMed
    Score: 0.023
  26. Lung involvement in systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb; 16(1):199-216.
    View in: PubMed
    Score: 0.019
  27. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum. 1989 May; 32(5):577-83.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.